Lacosamide Pain UCB Pharma (lacosamide)
- Region
- 🇪🇺 EU
- Active substance
- lacosamide
- Company
- UCB Pharma S.A.
- Status
- Application withdrawn
- Therapeutic area
- Diabetic Neuropathies
- Application
- EMEA/H/C/000894
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Lacosamide Accord Authorised · Accord Healthcare S.L.U.
- 🇪🇺 Lacosamide UCB Authorised · UCB Pharma S.A.
- 🇪🇺 Vimpat Authorised · UCB Pharma SA
- 🇪🇺 Lacosamide Adroiq Authorised · Extrovis EU Ltd
Follow Lacosamide Pain UCB Pharma
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.